Acumen Pharmaceuticals, Inc. (ABOS) Insider Trading

Name: Acumen Pharmaceuticals, Inc. (ABOS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 17, 2026): Derrell Porter (Director): Exercise/Conversion of 6,460 shares, $6.9K.

Get alerted when insiders trade ABOS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta